Hong Yu is a Neurology physician. ClinicalTrials.gov lists 9 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1493 Cambridge St
Cambridge, MA 021391099
Telephone
617-665-1552Provider last certified this registry record 15 Mar 2021.
Clinical trials
- Kombucha Tea for Improving Defecation in Patients With Schizophrenia- a Randomized Controlled Study
Sponsor: TsaoTun Psychiatric Center, Department of Health, Taiwan
- The Application of Thoracic Epidural Analgesia in Patients With Acute Pancreatitis
Sponsor: Sir Run Run Shaw Hospital
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
92.7%Other antiepileptics21.3%Levetiracetam63%Topiramate12%Lacosamide9%Vimpat6%Xcopri6%Levetiracetam Er5%Part D<11 patientsGabapentinoids11.7%Gabapentin86%Pregabalin14%Part D<11 patients+ 12 more classes in this area
Musculoskeletal
4.1%Neuromuscular Blocker2.7%Botox100%Part D≥13 patientsgamma-Aminobutyric Acid-ergic Agonist1.5%Baclofen100%Part D<11 patientsCardiovascular
3.2%Statin1.9%Atorvastatin Calcium100%Part D<11 patientsBeta blocker1.3%Propranolol Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
13 NIH research awards on record, funded 2012–2026 per NIH RePORTER. The latest:
- Social and behavioral determinants of health and Alzheimer’s Disease: Cohort study of the US military veteran population
University of Massachusetts Lowell
FY2026$1,477,571R01AG080670 - Social and behavioral determinants of MOUD utilization and opioid overdose
University of Massachusetts Lowell
FY2026$693,660R01DA056470 - Social and behavioral determinants of health and Alzheimer’s Disease: Cohort study of the US military veteran population
University of Massachusetts Lowell
FY2025$765,934R01AG080670
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Atte Meretoja
University of Helsinki
Bruce Miller, MD
University of California, San Francisco (UCSF)
Dennis Selkoe, MD
Brigham and Women's Hospital
Ettore Beghi
Mario Negri Institute for Pharmacological Research
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”